Long-term effects of laparoscopic sleeve gastrectomy in morbidly obese subjects with type 2 diabetes mellitus

Todkar, Jayashree S.; Shah, Shashank; Shah, Poonam; Gangwani, Jayashri

doi:10.1016/j.soard.2009.06.008

Cited by 67 publications

(28 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Our results also observed that the improvement in diabetes occur early in the postoperative course. It was also observed that while these changes occur early, they are also durable [24]. The findings are also comparable with a recent review of 27 studies of sleeve gastrectomy; in that 66% resolution of diabetes with a mean follow up of 13 months [25].…”

Section: Discussionsupporting

confidence: 87%

See 1 more Smart Citation

Wight Loss And Type II Diabetes Mellitus Control After Laparoscopic Sleeve Gastrectomy In An Early Post-Operative Period- A Prospective Cohort Study

Kumar¹,

Ansari²,

Verma³

et al. 2016

IOSR

View full text Add to dashboard Cite

Section: Discussionsupporting

confidence: 87%

“…A recent 3-year study of diabetic patients after LSG demonstrated an improvement in all comorbidities in 70% of patients [24]. Significant improvement /remission of diabetic markers like Blood sugar level Fasting as well as PP), HbA1c is commonly observed after bariatric surgery [25][26][27].…”

Section: Discussionmentioning

confidence: 99%

Wight Loss And Type II Diabetes Mellitus Control After Laparoscopic Sleeve Gastrectomy In An Early Post-Operative Period- A Prospective Cohort Study

Kumar¹,

Ansari²,

Verma³

et al. 2016

IOSR

View full text Add to dashboard Cite

“…Numerous studies have demonstrated that bariatric surgery is more efficient in the management of morbid obesity than conservative medical treatment [10][11][12][13][14]. Bariatric surgery has evolved over the last years from open surgery to tiny incisions, and, currently, one of the most popular operations in bariatric surgery is laparoscopic sleeve gastrectomy (LSG).…”

Section: Discussionmentioning

confidence: 99%

Single Incision Laparoscopic Sleeve Gastrectomy: a Review

Stefanopoulos¹,

Economopoulos

Kalles

2015

OBES SURG

View full text Add to dashboard Cite

We aim to summarize the existing evidence on the use of single incision sleeve gastrectomy (SILSG) for morbid obesity. A thorough literature search for studies reporting outcomes of SILSG was performed. Data on patient demographics, operative details, and surgical outcomes were analyzed. Sixteen studies incorporating 945 patients (90.6 % women) with a mean age of 37 years were included in the analysis. A commercially available single-port device was used in 89.7 % of the cases. The mean operative time was 64.7 min, with two cases (0.2 %) of intraoperative and 27 cases (2.8 %) of postoperative complications. There were no perioperative deaths reported, while the mean postoperative hospital stay was 2.5 days. SILSG is a feasible and safe approach, with low complication and mortality rates in carefully selected patients.

show abstract

“…As for the weight loss, how much of the resolution of T2DM was related to the sleeve gastrectomy or to the ileal interposition is still difficult to ascertain. Todkar et al [26] mentioned that 16 (69.6%) of 23 patients resolved their T2DM with a SG after a mean follow-up of 36 months. Rosenthal et al [27] reported 63% resolution rates at 6 months of follow-up.…”

Section: Discussionmentioning

confidence: 99%

Surgical Treatment of Morbid Obesity: Mid-term Outcomes of the Laparoscopic Ileal Interposition Associated to a Sleeve Gastrectomy in 120 Patients

DePaula¹,

Stival

Halpern

et al. 2010

OBES SURG

View full text Add to dashboard Cite

The aim of this study was to evaluate the mid-term outcomes of the laparoscopic ileal interposition associated to a sleeve gastrectomy (LII-SG) for the treatment of morbid obesity. The procedure was performed in 120 patients: 71 women and 49 men with mean age of 41.4 years. Mean body mass index (BMI) was 43.4 ± 4.2 kg/m². Patients had to meet requirements of the 1991 NIH conference criteria for bariatric operations. Associated comorbidities were observed in all patients, including dyslipidemia in 51.7%, hypertension in 35.8%, type 2 diabetes in 15.8%, degenerative joint disease in 55%, gastroesophageal reflux disease in 36.7%, sleep apnea in 10%, and cardiovascular problems in 5.8%. Mean follow-up was 38.4 ± 10.2 months, range 25.2-61.1. There was no conversion to open surgery nor operative mortality. Early major complications were diagnosed in five patients (4.2%). Postoperatively, 118 patients were evaluated. Late major complications were observed in seven patients (5.9%). Reoperations were performed in six (5.1%). Mean postoperative BMI was 25.7 ± 3.17 kg/m², and 86.4% were no longer obese. Mean %EWL was 84.5 ± 19.5%. Hypertension was resolved in 88.4% of the patients, dyslipidemia in 82.3%, and T2DM in 84.2%. The LII-SG provided an adequate weight loss and resolution of associated diseases during mid-term outcomes evaluation. There was an acceptable morbidity with no operative mortality. It seems that chronic ileal brake activation determined sustained reduced food intake and increased satiety over time. LII-SG could be regularly used as a surgical alternative for the treatment of morbid obesity.

show abstract

Long-term effects of laparoscopic sleeve gastrectomy in morbidly obese subjects with type 2 diabetes mellitus

Cited by 67 publications

References 20 publications

Wight Loss And Type II Diabetes Mellitus Control After Laparoscopic Sleeve Gastrectomy In An Early Post-Operative Period- A Prospective Cohort Study

Wight Loss And Type II Diabetes Mellitus Control After Laparoscopic Sleeve Gastrectomy In An Early Post-Operative Period- A Prospective Cohort Study

Single Incision Laparoscopic Sleeve Gastrectomy: a Review

Surgical Treatment of Morbid Obesity: Mid-term Outcomes of the Laparoscopic Ileal Interposition Associated to a Sleeve Gastrectomy in 120 Patients

Contact Info

Product

Resources

About